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The work of this study was conducted in Brisbane, Queensland, Australia 
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To the Editor, 
The risk of developing cutaneous melanoma increases with increasing numbers of common 
naevi on the skin (Olsen et al., 2010). It is estimated that around 50% of melanomas may 
develop from a naevus, especially melanomas in younger people and of the superficial 
spreading subtype (Cymerman et al., 2016), although the exact proportion is debated (Purdue 
et al., 2005, Shain and Bastian, 2016, Shitara et al., 2014, Tsao et al., 2003). Therefore much 
can be learned from studying naevi, yet little is known about their natural history in the 
general population. Studies to date have shown a lower prevalence of naevi in older age-
groups, but since these have been all cross-sectional in design, they do not address natural 
history which can only be loosely inferred from their findings (Green and Swerdlow, 1989, 
Piliouras et al., 2011, Stegmaier, 1959). For example, the lower prevalence in older age 
groups may be due to the generally lower sun exposure in earlier time periods (cohort effect) 
rather than an age-effect (Bolanca et al., 2008). Almost all longitudinal studies have been 
undertaken in high-risk groups such as melanoma patients, their relatives or atypical naevus 
patients (Abbott et al., 2015, Banky et al., 2005, Halpern et al., 1993) and their findings are 
unlikely to apply to the population at large. Therefore, we performed a systematic review of 
longitudinal studies of naevus counts in the general population. 
 
Population-based longitudinal studies in adults (>18 y) that consisted of a baseline and at 
least one follow-up count of common naevi were included. The guidelines from the Preferred 
Reporting Items for systematic Reviews and Meta-Analyses (PRISMA) statement were 
followed for reporting of the review (Moher et al., 2009). Inclusion criteria and methods of 
data analysis were specified in advance and documented 
(http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42016049474). 
Eligible studies to 20 September 2016 were identified by searching Medline 1950 (U.S. 
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National Library of Medicine, Bethesda, MD; using PubMed software as the search interface) 
and hand-searching the reference lists of the retrieved articles. The following medical subject 
headings, terms, or text words were used: “naevus”, "naevi", "nevus", "nevi", "melanocytic 
naevi", "nevus, pigmented", “cohort”, "longitudinal studies” and “prospective”. First, titles 
and abstracts from retrieved articles were screened by 2 review authors (EP and TN). 
Subsequently full-texts of potentially relevant articles were assessed for eligibility by the 
same 2 reviewers. Any discrepancy was resolved by consensus. No attempt was made to 
identify unpublished literature. Authors of one article were contacted per email for further 
information but did not respond.  
 
708 studies were identified, of which two met the inclusion criteria (Table 1) (Flow chart as 
supplementary material). The first study (Tindall, 1976) examined 163 people reflecting the 
sex, race and socioeconomic status of the ambulatory population of Durham, North Carolina, 
USA, aged 64 years and over. Naevi were counted on the total body among other skin 
conditions.  After 10 years of follow-up the counts were repeated on 69 living participants of 
the original 163 (42%). At follow-up, the percentage of people with ten or more naevi 
decreased to 7%, compared to 15% at baseline (Table 1). Exact numbers of naevi were not 
provided and no information was given about changes in people with less than 10 naevi at 
baseline.  
 
The second study (Koseoglu et al., 2015) conducted in Turkey included 60 healthy controls 
as part of a study examining naevus growth in patients receiving immunosuppressive 
treatment. Controls were matched to the cases by age, sex, race and Fitzpatrick skin type. 
Naevi were counted at baseline, 3, 6 and 12 months on the trunk, arms and legs; however, 
only the baseline and 12-month results were presented. In addition to the naevus count, size 
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of the naevi was dermoscopically measured and any dermoscopic changes were noted. In 
total 180 melanocytic lesions were counted. No changes in naevus counts were observed after 
12 months (p= 0.564), nor were any dermoscopic changes noted, but the median size of the 
naevi had decreased from 3.01 to 2.98 (p< 0.001) (Table 1).  
 
Both studies have major limitations. In the US study (Tindall, 1976) age, sex and race 
distributions of the study population were not provided, and no exact naevus counts were 
given overall or within demographic strata. The authors of the Turkish study (Koseoglu et al., 
2015) did not specify from where or how the 60 matched controls were recruited and how 
representative they were of the general population. Neither did they note if there was any loss 
to follow up. Also, the significance of the decrease in median naevus size they report seems 
unlikely given the small difference and sample size. For both studies (Koseoglu et al., 2015, 
Tindall, 1976) no description was given of the examiners or the counting and size 
measurement procedure, and thus the accuracy of the data is unable to be assessed. 
 
Our review highlights a major gap in scientific knowledge regarding the natural history of 
common melanocytic naevi. While numerous reports from cross-sectional studies suggest 
that older populations generally have lower nevus counts, implying that common naevi 
involute over time (Green and Swerdlow, 1989), this evidence may merely reflect a cohort 
effect not a true age effect. The US study found a decline in the proportion of people aged 64 
years and over with 10 or more naevi in a 10-year period (Tindall, 1976), while the Turkish 
study did not find changes in naevus counts over 12 months in their study population with a 
mean age of 44 years (Koseoglu et al., 2015). Both these studies have reported very limited 
longitudinal data which hamper interpretation and generalisation of the findings. 
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It is crucial to have longitudinal data on normal naevus development in all age groups in the 
general population as these are the strongest determinants of melanoma. Such knowledge will 
lead to better understanding of evolution of naevocytes or melanocytes if it occurs. Providing 
this missing link in naevus (and melanoma) aetiology would potentially help in tailoring 
secondary prevention strategies for melanoma. In conclusion, this review highlights the need 
for longitudinal naevus research in the general population to develop further knowledge on 
the natural history of naevi.  
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Table 1. Longitudinal naevus counts: comparison of results from two cohorts 
 Tindall et al., 1976(Tindall, 
1976) 
Koseoglu et al., 
2015(Koseoglu et al., 2015) 
Study location North Carolina, USA Turkey 
Cohort size 69 60 
Cohort description Reflection of the ambulant 
population of Durham, NC, 
aged 64 and over, survivors 
after 10 year follow up of 
original cohort of 163 
persons 
Healthy controls, matched by 
age, sex, race and Fitzpatrick 
skin type to 103 patients 
undergoing 
immunosuppressive therapy 
Follow up 10 years 12 months 
Mean age Not stated 44 +-10.32 (SD) 
Male, % Not stated 40 
Naevus count Total body Trunk, arms and legs 
No. of naevi % of people with 10 or 
more naevi 
Mean no. of naevi (min-
max) 
At baseline 15% 4 (1-12) 
At follow up 7% 4 (1-12) 
Size of naevi: Median diameter in mm (min-max)  
At baseline N/A 3.01 (2.04-7.55) 
At follow up N/A 2.98 (2.00-7.77) 
 
 
 
 
 
 
